IACH News Podcasts

Give the high rate of advances in the field of clinical hematology, the IACH News initiative enables experts in the field and key opinion leaders share the most up to date information in a timely manner, and in a format that is, focused, engaging and easy to access.

May 21st- From Dysbiosis to Therapeutics: The New Era of Microbiota in Allo-HCT

CME Congresses .

May 21st- From Dysbiosis to Therapeutics: The New Era of Microbiota in Allo-HCT

May 18th- Can Peripheral Blood Replace Bone Marrow for MRD Monitoring in Myeloma?

CME Congresses .

May 18th- Can Peripheral Blood Replace Bone Marrow for MRD Monitoring in Myeloma?

May 11th- Beyond the webinar: ISKIA and the New Era of MRD-Driven Myeloma Therapy: Are We Moving Closer to Cure?

CME Congresses .

May 11th- Beyond the webinar: ISKIA and the New Era of MRD-Driven Myeloma Therapy: Are We Moving Closer to Cure?

May 8th- Beyond the webinar: Multiple Myeloma in 2026: Innovation Meets Reality – Lessons from the Australian Experience

CME Congresses .

May 8th- Beyond the webinar: Multiple Myeloma in 2026: Innovation Meets Reality – Lessons from the Australian Experience

May 7th- Beyond the webinar: Busulfan in Hematology – From Empiricism to Precision Conditioning

CME Congresses .

May 7th- Beyond the webinar: Busulfan in Hematology – From Empiricism to Precision Conditioning

May 4th- Reinventing Drug Delivery in Multiple Myeloma: The Rise of the On-Body Injector for Isatuximab

CME Congresses .

May 4th- Reinventing Drug Delivery in Multiple Myeloma: The Rise of the On-Body Injector for Isatuximab

May 1st- Beyond the Webinar: CAR-T Cells- From Breakthrough to Global Transformation

CME Congresses .

May 1st- Beyond the Webinar: CAR-T Cells- From Breakthrough to Global Transformation

May 5th- Dr. Neta Nevo- Diagnosis and management of AML in pediatric patients: consensus recommendations from an international expert panel

CME Congresses .

May 5th- Dr. Neta Nevo- Diagnosis and management of AML in pediatric patients: consensus recommendations from an international expert panel

April 27th- Prof. Robert Zeiser- Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AML

CME Congresses .

April 27th- Prof. Robert Zeiser- Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AML

April 22nd- Hepta-Refractory Myeloma: When Targets Disappear

CME Congresses .

April 22nd- Hepta-Refractory Myeloma: When Targets Disappear